IMRT QA: Selecting gamma criteria based on error detection sensitivity

Medical Physics

Volumn 43, Issue 4, 2016, Pages 1982-1994

  Steers, Jennifer M ^a,b   Fraass, Benedick A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

error curve method; gamma criteria sensitivity; gamma passing rates; IMRT QA; IMRT QA tolerances

Indexed keywords

PIXELS; QUALITY CONTROL; RADIOTHERAPY; RANDOM ERRORS; SYSTEMATIC ERRORS;

CURVE METHOD; ERROR CURVE METHOD; ERROR CURVES; GAMMA CRITERIA SENSITIVITY; GAMMA PASSING RATE; INTENSITY MODULATED RADIATION THERAPY QUALITY ASSURANCE; INTENSITY MODULATED RADIATION THERAPY QUALITY ASSURANCE TOLERANCE; INTENSITY-MODULATED RADIATION THERAPY; QUANTITATIVE DETERMINATIONS;

QUALITY ASSURANCE;

ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; DOSIMETER; DOSIMETRY; ERROR CURVE METHOD; GAMMA RADIATION; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; MULTILEAF COLLIMATOR; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; RANDOM ERROR; SYSTEMATIC ERROR; HEALTH CARE QUALITY; HUMAN; METHODOLOGY; PROCEDURES; RADIOTHERAPY PLANNING SYSTEM; STANDARDS;

HUMANS; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RESEARCH DESIGN;

EID: 84963770158     PISSN: 00942405     EISSN: 24734209     Source Type: Journal    
DOI: 10.1118/1.4943953     Document Type: Article

References (49)

1. G. A. Ezzell, J. M. Galvin, D. Low, J. R. Palta, I. Rosen, M. B. Sharpe, P. Xia, Y. Xiao, L. Xing, and X. Y. Cedric, "Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee," Med. Phys. 30, 2089-2115 (2003). 10.1118/1.1591194
2. D. A. Low, J. M. Moran, J. F. Dempsey, L. Dong, and M. Oldham, "Dosimetry tools and techniques for IMRT," Med. Phys. 38, 1313-1338 (2011). 10.1118/1.3514120
3. J. M. Moran, M. Dempsey, A. Eisbruch, B. A. Fraass, J. M. Galvin, G. S. Ibbott, and L. B. Marks, "Safety considerations for IMRT: Executive summary," Pract. Radiat. Oncol. 1, 190-195 (2011). 10.1016/j.prro.2011.04.008
4. A. C. Hartford, J. M. Galvin, D. C. Beyer, T. J. Eichler, G. S. Ibbott, B. Kavanagh, C. J. Schultz, and S. A. Rosenthal, "American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for intensity-modulated radiation therapy (IMRT)," Am. J. Clin. Oncol. 35, 612-617 (2012). 10.1097/COC.0b013e31826e0515
5. D. A. Low, W. B. Harms, S. Mutic, and J. A. Purdy, "A technique for the quantitative evaluation of dose distributions," Med. Phys. 25, 656-661 (1998). 10.1118/1.598248
6. D. A. Low and J. F. Dempsey, "Evaluation of the gamma dose distribution comparison method," Med. Phys. 30, 2455-2464 (2003). 10.1118/1.1598711
7. G. A. Ezzell, J. W. Burmeister, N. Dogan, T. J. LoSasso, J. G. Mechalakos, D. Mihailidis, A. Molineu, J. R. Palta, C. R. Ramsey, and B. J. Salter, "IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119," Med. Phys. 36, 5359-5373 (2009). 10.1118/1.3238104
8. S. Both, I. M. Alecu, A. R. Stan, M. Alecu, A. Ciura, J. M. Hansen, and R. Alecu, "A study to establish reasonable action limits for patient-specific quality assurance in intensity-modulated radiation therapy," J. Appl. Clin. Med. Phys. 8, 1-8 (2007). 10.1120/jacmp.v8i2.2374
9. R. M. Howell, I. P. Smith, and C. S. Jarrio, "Establishing action levels for EPID-based QA for IMRT," J. Appl. Clin. Med. Phys. 9, 16-25 (2008). 10.1120/jacmp.v9i3.2721
10. P. S. Basran and M. K. Woo, "An analysis of tolerance levels in IMRT quality assurance procedures," Med. Phys. 35, 2300-2307 (2008). 10.1118/1.2919075
11. A. J. Vinall, A. J. Williams, V. E. Currie, A. Van Esch, and D. Huyskens, "Practical guidelines for routine intensity-modulated radiotherapy verification: Pre-treatment verification with portal dosimetry and treatment verification with in vivo dosimetry," Br. J. Radiol. 83, 949-957 (2010). 10.1259/bjr/31573847
12. P. Carrasco, N. Jornet, A. Latorre, T. Eudaldo, A. Ruiz, and M. Ribas, "3D DVH-based metric analysis versus per-beam planar analysis in IMRT pretreatment verification," Med. Phys. 39, 5040-5049 (2012). 10.1118/1.4736949
13. F. Garcia-Vicente, V. Fernandez, R. Bermudez, A. Gomez, L. Perez, A. Zapatero, and J. J. Torres, "Sensitivity of a helical diode array device to delivery errors in IMRT treatment and establishment of tolerance level for pretreatment QA," J. Appl. Clin. Med. Phys. 13, 111-123 (2012). 10.1120/jacmp.v13i1.3660
14. T. Pawlicki, S. Yoo, L. E. Court, S. K. McMillan, R. K. Rice, J. D. Russell, J. M. Pacyniak, M. K. Woo, P. S. Basran, A. L. Boyer, and C. Bonilla, "Process control analysis of IMRT QA: Implications for clinical trials," Phys. Med. Biol. 53, 5193-5205 (2008). 10.1088/0031-9155/53/18/023
15. X. Jin, H. Yan, C. Han, Y. Zhou, J. Yi, and C. Xie, "Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification," Br. J. Radiol. 88, 20140577 (2015). 10.1259/bjr.20140577
16. A. K. Templeton, J. C. Chu, and J. V. Turian, "The sensitivity of ArcCHECK-based gamma analysis to manufactured errors in helical tomotherapy radiation delivery," J. Appl. Clin. Med. Phys. 16, 32-39 (2015). 10.1120/jacmp.v16i1.4814
17. L. Vieillevigne, J. Molinier, T. Brun, and R. Ferrand, "Gamma index comparison of three VMAT QA systems and evaluation of their sensitivity to delivery errors," Phys. Med. 31, 720-725 (2015). 10.1016/j.ejmp.2015.05.016
18. G. Yan, C. Liu, T. Simon, L.-C. Peng, C. Fox, and J. Li, "On the sensitivity of patient-specific IMRT QA to MLC positioning errors," J. Appl. Clin. Med. Phys. 10, 120-128 (2009). 10.1120/jacmp.v10i1.2915
19. B. E. Nelms, H. Zhen, and W. A. Tomé, "Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors," Med. Phys. 38, 1037-1044 (2011). 10.1118/1.3544657
20. H. Zhen, B. E. Nelms, and W. A. Tomé, "Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA," Med. Phys. 38, 5477-5489 (2011). 10.1118/1.3633904
21. M. Stasi, S. Bresciani, A. Miranti, A. Maggio, V. Sapino, and P. Gabriele, "Pretreatment patient-specific IMRT quality assurance: A correlation study between gamma index and patient clinical dose volume histogram," Med. Phys. 39, 7626-7634 (2012). 10.1118/1.4767763
22. B. E. Nelms, M. F. Chan, G. Jarry, M. Lemire, J. Lowden, C. Hampton, and V. Feygelman, "Evaluating IMRT and VMAT dose accuracy: Practical examples of failure to detect systematic errors when applying a commonly used metric and action levels," Med. Phys. 40, 111722 (15pp.) (2013). 10.1118/1.4826166
23. B. Nelms, G. Jarry, M. Chan, C. Hampton, Y. Watanabe, and V. Feygelman, "Real-world examples of sensitivity failures of the 3%/3 mm pass rate metric and published action levels when used in IMRT/VMAT system commissioning," J. Phys.: Conf. Ser. 444, 012086 (2013). 10.1088/1742-6596/444/1/012086
24. M. F. Chan, J. Li, K. Schupak, and C. Burman, "Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: Clinical head and neck case studies," Technol. Cancer Res. Treat. 13, 57-67 (2014). 10.7785/tcrt.2012.500353
25. C. Bojechko and E. C. Ford, "Quantifying the performance of in vivo portal dosimetry in detecting four types of treatment parameter variations," Med. Phys. 42, 6912-6918 (2015). 10.1118/1.4935093
26. S. F. Kry, A. Molineu, J. R. Kerns, A. M. Faught, J. Y. Huang, K. B. Pulliam, J. Tonigan, P. Alvarez, F. Stingo, and D. S. Followill, "Institutional patient-specific IMRT QA does not predict unacceptable plan delivery," Int. J. Radiat. Oncol., Biol., Phys. 90, 1195-1201 (2014). 10.1016/j.ijrobp.2014.08.334
27. J. J. Kruse, "On the insensitivity of single field planar dosimetry to IMRT inaccuracies," Med. Phys. 37, 2516-2524 (2010). 10.1118/1.3425781
28. E. M. McKenzie, P. A. Balter, F. C. Stingo, J. Jones, D. S. Followill, and S. F. Kry, "Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans," Med. Phys. 41, 121702 (14 pp.) (2014). 10.1118/1.4899177
29. B. E. Nelms and J. A. Simon, "A survey on IMRT QA analysis," J. Appl. Clin. Med. Phys. 8, 76-90 (2007). 10.1120/jacmp.v8i3.2448
30. M. Hussein, P. Rowshanfarzad, M. A. Ebert, A. Nisbet, and C. H. Clark, "A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems," Radiother. Oncol. 109, 370-376 (2013). 10.1016/j.radonc.2013.08.048
31. T. Sanghangthum, S. Suriyapee, S. Srisatit, and T. Pawlicki, "Statistical process control analysis for patient-specific IMRT and VMAT QA," J. Radiat. Res. 54, 546-552 (2013). 10.1093/jrr/rrs112
32. N. Wen, B. Zhao, J. Kim, K. Chin-Snyder, M. Bellon, C. Glide-Hurst, K. Barton, D. Chen, and I. J. Chetty, "IMRT and RapidArc commissioning of a TrueBeam linear accelerator using TG-119 protocol cases," J. Appl. Clin. Med. Phys. 15, 74-88 (2014). 10.1120/jacmp.v15i5.4843
33. G. M. Mancuso, J. D. Fontenot, J. P. Gibbons, and B. C. Parker, "Comparison of action levels for patient-specific quality assurance of intensity modulated radiation therapy and volumetric modulated arc therapy treatments," Med. Phys. 39, 4378-4385 (2012). 10.1118/1.4729738
34. T. Pawlicki, S. Yoo, L. E. Court, S. K. McMillan, R. K. Rice, J. D. Russell, J. M. Pacyniak, M. K. Woo, P. S. Basran, J. Shoales, and A. L. Boyer, "Moving from IMRT QA measurements toward independent computer calculations using control charts," Radiother. Oncol. 89, 330-337 (2008). 10.1016/j.radonc.2008.07.002
35. C. Neilson, M. Klein, R. Barnett, and S. Yartsev, "Delivery quality assurance with ArcCHECK," Med. Dosim. 38, 77-80 (2013). 10.1016/j.meddos.2012.07.004
36. K. B. Pulliam, D. Followill, L. Dong, M. Gillin, K. Prado, and S. F. Kry, "A six-year review of more than 13,000 patient-specific IMRT QA results from 13 different treatment sites," J. Appl. Clin. Med. Phys. 15, 196-206 (2014). 10.1120/jacmp.v15i5.4935
37. S. Bresciani, A. Di Dia, A. Maggio, C. Cutaia, A. Miranti, E. Infusino, and M. Stasi, "Tomotherapy treatment plan quality assurance: The impact of applied criteria on passing rate in gamma index method," Med. Phys. 40, 121711 (6 pp.) (2013). 10.1118/1.4829515
38. W. Cruz, G. Narayanasamy, M. Regan, P. Mavroidis, N. Papanikolaou, C. S. Ha, and S. Stathakis, "Patient specific IMRT quality assurance with film, ionization chamber and detector arrays: Our institutional experience," Radiat. Phys. Chem. 115, 12-16 (2015). 10.1016/j.radphyschem.2015.06.002
39. V. Feygelman, G. Zhang, C. Stevens, and B. E. Nelms, "Evaluation of a new VMAT QA device, or the 'X' and 'O' array geometries," J. Appl. Clin. Med. Phys. 12, 146-168 (2011). 10.1120/jacmp.v12i2.3346
40. D. W. Bailey, B. E. Nelms, K. Attwood, L. Kumaraswamy, and M. B. Podgorsak, "Statistical variability and confidence intervals for planar dose QA pass rates," Med. Phys. 38, 6053-6064 (2011). 10.1118/1.3651695
41. D. Létourneau, J. Publicover, J. Kozelka, D. J. Moseley, and D. A. Jaffray, "Novel dosimetric phantom for quality assurance of volumetric modulated arc therapy," Med. Phys. 36, 1813-1821 (2009). 10.1118/1.3117563
42. G. Yan, B. Lu, J. Kozelka, C. Liu, and J. G. Li, "Calibration of a novel four-dimensional diode array," Med. Phys. 37, 108-115 (2010). 10.1118/1.3266769
43. J. Kozelka, J. Robinson, B. Nelms, G. Zhang, D. Savitskij, and V. Feygelman, "Optimizing the accuracy of a helical diode array dosimeter: A comprehensive calibration methodology coupled with a novel virtual inclinometer," Med. Phys. 38, 5021-5032 (2011). 10.1118/1.3622823
44. R. M. Howell, S. B. Scarboro, S. Kry, and D. Z. Yaldo, "Accuracy of out-of-field dose calculations by a commercial treatment planning system," Phys. Med. Biol. 55, 6999-7008 (2010). 10.1088/0031-9155/55/23/S03
45. See supplementary material at http://dx.doi.org/10.1118/1.4943953 E-MPHYA6-43-028604 for additional error curve data.
46. J.-H. Song, M.-J. Kim, S.-H. Park, S.-R. Lee, M.-Y. Lee, D. S. Lee, and T. S. Suh, "Gamma analysis dependence on specified low-dose thresholds for VMAT QA," J. Appl. Clin. Med. Phys. 16, 263-272 (2015). 10.1120/jacmp.v16i6.5696
47. C. Wu, K. E. Hosier, K. E. Beck, M. B. Radevic, J. Lehmann, H. H. Zhang, A. Kroner, S. C. Dutton, S. A. Rosenthal, J. K. Bareng, M. D. Logsdon, and D. R. Asche, "On using 3D gamma-analysis for IMRT and VMAT pretreatment plan QA," Med. Phys. 39, 3051-3059 (2012). 10.1118/1.4711755
48. A. Carver, M. Gilmore, S. Riley, J. Uzan, and P. Mayles, "An analytical approach to acceptance criteria for quality assurance of intensity modulated radiotherapy," Radiother. Oncol. 100, 453-455 (2011). 10.1016/j.radonc.2011.08.045
49. J. I. Kim, S. Y. Park, H. J. Kim, J. H. Kim, S. J. Ye, and J. M. Park, "The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT," Radiat. Oncol. 9, 167-178 (2014). 10.1186/1748-717X-9-167